×
About 1,435 results

ALLMedicine™ Androgen Excess Center

Research & Reviews  433 results

Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ...
https://doi.org/10.1093/humrep/dead043
Human Reproduction (Oxford, England); Insenser M, Quintero A et. al.

Mar 18th, 2023 - Circulating miRNAs previously associated with androgen excess in women might be used as diagnostic biomarkers for polycystic ovary syndrome (PCOS). Models based on circulating miR-142-3p and miR-598-3p expression show good discrimination among wom...

Natural History Study of Patients With Excess Androgen
https://clinicaltrials.gov/ct2/show/NCT00250159

Mar 3rd, 2023 - Study Description: Androgen excess in childhood results in pseudoprecocious puberty, accelerated childhood growth with premature epiphyseal fusion, adult short stature, and unknown metabolic and psychological perturbations. Congenital Adrenal Hype...

Updates in diagnosing polycystic ovary syndrome-related infertility.
https://doi.org/10.1080/14737159.2023.2177536
Expert Review of Molecular Diagnostics; Haddad-Filho H, Tosatti JAG et. al.

Mar 2nd, 2023 - Polycystic ovary syndrome (PCOS) is a condition that affects approximately 13% of reproductive age women and is characterized by androgen excess, menstrual irregularity and altered ovarian morphology. PCOS presents a complex etiology and pathophys...

Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adh...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933286
BMC Women's Health; Yousuf SD, Ganie MA et. al.

Feb 17th, 2023 - Polycystic ovary syndrome (PCOS) presents clinical symptoms of menstrual abnormalities, excessive hair growth (hirsutism), scalp hair loss, acne and infertility. Metabolic abnormalities such as obesity, insulin resistance, glucose intolerance and ...

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
https://clinicaltrials.gov/ct2/show/NCT02574910

Feb 17th, 2023 - Congenital adrenal hyperplasia (CAH) is an inherited inability to synthesize cortisol in the adrenal gland. More than 90% of cases are cause by deficiency of steroid 21-hydroxylase (CYP21, also termed CYP21A2, P450c21), which is a cytochrome P450 ...

see more →

Guidelines  5 results

Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Andro...
https://doi.org/10.1210/jc.2018-02548
The Journal of Clinical Endocrinology and Metabolism; Carmina E, Azziz R et. al.

Feb 21st, 2019 - To determine the current state of knowledge and provide evidence-based recommendations that could be valid for all specialists taking care of female pattern hair loss (FPHL), a common form of hair loss in women that is characterized by the reducti...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, A...
https://doi.org/10.4158/EP15748.DSCPT2
Endocrine Practice : Official Journal of the American Col... Goodman NF, Cobin RH et. al.

Dec 8th, 2015 - Polycystic ovary syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists and the Androge...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, A...
https://doi.org/10.4158/EP15748.DSC
Endocrine Practice : Official Journal of the American Col... Goodman NF, Cobin RH et. al.

Oct 29th, 2015 - Polycystic Ovary Syndrome (PCOS) is recognized as the most common endocrine disorder of reproductive-aged women around the world. This document, produced by the collaboration of the American Association of Clinical Endocrinologists (AACE) and the ...

The polycystic ovary syndrome: a position statement from the European Society of Endocr...
https://doi.org/10.1530/EJE-14-0253
European Journal of Endocrinology; Conway G, Dewailly D et. al.

May 23rd, 2014 - Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with androgen excess in women, which justifies the growing interest of endocrinologists. Great efforts have been made in the last 2 decades to define the syndrome. The...

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Andro...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.

Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  53 results

Natural History Study of Patients With Excess Androgen
https://clinicaltrials.gov/ct2/show/NCT00250159

Mar 3rd, 2023 - Study Description: Androgen excess in childhood results in pseudoprecocious puberty, accelerated childhood growth with premature epiphyseal fusion, adult short stature, and unknown metabolic and psychological perturbations. Congenital Adrenal Hype...

Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
https://clinicaltrials.gov/ct2/show/NCT02574910

Feb 17th, 2023 - Congenital adrenal hyperplasia (CAH) is an inherited inability to synthesize cortisol in the adrenal gland. More than 90% of cases are cause by deficiency of steroid 21-hydroxylase (CYP21, also termed CYP21A2, P450c21), which is a cytochrome P450 ...

Hysteroscopic Findings in Ovarian Polycystic and Unexplained Infertile Women.
https://clinicaltrials.gov/ct2/show/NCT05042895

Feb 8th, 2023 - Aim of the work The study aimed to evaluate post menstrual hysteroscopic findings in ovarian PCO and unexplained infertility and correlate them with TVS findings and final histopathologic diagnosis. Methodology: Study design: A cross-sectional stu...

Androgen Reduction in Congenital Adrenal Hyperplasia
https://clinicaltrials.gov/ct2/show/NCT03548246

Feb 1st, 2023 - Congenital adrenal hyperplasia (CAH) is an inherited inability to synthesize cortisol in the adrenal gland. More than 90% of cases are cause by deficiency of steroid 21-hydroxylase (CYP21, also termed CYP21A2, P450c21), which is a cytochrome P450 ...

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2
https://clinicaltrials.gov/ct2/show/NCT05647356

Dec 12th, 2022 - Background: Polycystic ovary syndrome (PCOS) is a lifelong metabolic disorder affecting 10-13% of all women and is associated with major healthcare and economic burden, estimated at $8 billion annually the US in 2020. Traditionally considered a re...

see more →

News  76 results

Simplify your approach to the diagnosis and treatment of PCOS
https://www.mdedge.com/obgyn/article/260094/gynecology/simplify-your-approach-diagnosis-and-treatment-pcos
Robert L. Barbieri, MD

Dec 13th, 2022 - PCOS is a common problem, with a prevalence of 6% to 10% among women of reproductive age. 1 Patients with PCOS often present with hirsutism, acne, female androgenetic alopecia, oligomenorrhea (also known as infrequent menstrual bleeding), amenorrhe.

Emerging Neuroendocrine Involvement Driving Research in PCOS
https://www.medscape.com/viewarticle/980292

Sep 6th, 2022 - Polycystic ovary syndrome (PCOS) affects an estimated 8%-13% of women, and yet "it has been quite a black box for many years," as Margo Hudson, MD, an assistant professor of endocrinology, diabetes, and hypertension at Harvard Medical School, Bost...

Hormonal therapy a safe, long term option for older women with recalcitrant acne
https://www.mdedge.com/dermatology/article/257514/acne/hormonal-therapy-safe-long-term-option-older-women-recalcitrant-acne
Doug Brunk

Aug 31st, 2022 - PORTLAND, ORE. – During her dermatology residency training at the University of California, Irvine, Medical Center, Jenny Murase, MD, remembers hearing a colleague say that her most angry patients of the day were adult women with recalcitrant acne.

State of the science in PCOS: Emerging neuroendocrine involvement driving research
https://www.mdedge.com/obgyn/article/257387/reproductive-endocrinology/state-science-pcos-emerging-neuroendocrine
Tara Haelle

Aug 26th, 2022 - Polycystic ovary syndrome (PCOS) affects an estimated 8%-13% of women, and yet “it has been quite a black box for many years,” as Margo Hudson, MD, an assistant professor of endocrinology, diabetes, and hypertension at Harvard Medical School, Bost.

Can the Ketogenic Diet Treat Polycystic Ovary Syndrome? 
https://www.medscape.com/viewarticle/975737

Jun 16th, 2022 - MADRID — During the International Scientific Symposium "New Frontiers in Scientific Research" that recently took place in Barcelona, specialists analyzed the role of the very-low-calorie ketogenic diet. This analysis was in relation to three comor...

see more →

Patient Education  2 results see all →